Sign Up to like & get
recommendations!
0
Published in 2019 at "Antiviral Therapy"
DOI: 10.3851/imp3322
Abstract: Background Patients with chronic HCV infection are at increased risk of developing B-cell non-Hodgkin lymphoma (B-NHL). Regression of HCV-associated B-NHL (HCV-NHL) can be achieved through HCV eradication using interferon (IFN). However, only about two-thirds of…
read more here.
Keywords:
hcv nhl;
antiviral therapy;
mirna 26b;
response ... See more keywords